Tommy Lee
Autoimmunity & Oncology Pancar (in Vivo Car) - Associate Director @Orna Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Autoimmunity & Oncology Pancar (in Vivo Car) - Associate Director @Orna Therapeutics
Eli Lilly acquired Orna Therapeutics in 2026- Presented ORN-252 pre-clinical data at Scientist.com & StemCell\'s Webinar Series- Supported Orna\'s Autoimmunity Clinical Trial Applications for ORN-252- Collaborated with pre-clinical and clinical translation team to establish ORN-252\'s & ORN-210\'s pharmacology package - Wrote and reviewed technical report for ORN-252 & ORN-210\'s pre-clinical pharmacology package- Managed 7 direct reports - 1 Prin. Scientist, 1 Scientists, 3 non-PhD FTEs, & 2 co-op interns
EDUCATION
Baylor College of Medicine
Doctor of Philosophy (Ph.D.)
ABOUT TOMMY LEE
An immunologist with industry research experience in diseases, ranging from autoimmunity, immuno-oncology, infectious diseases, and allergy-induced asthma. Established multiple collaborations with internal teams, companies, and academics to push pre-clinical work toward a developmental candidacy or clinical indication. Specialties: immunology, biotechnology, research & development, collaborator, life science, T cell-mediated autoimmunity, immuno-oncology, chimeric antigen receptors, antigen presentation, allergy-induced asthma, infectious diseases, vaccines, immunogenicity, reactogenicity, immuno-therapies, cellular therapies, animal models, human studies, leadership, and mentoring
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.